Neville Rodie & Shaw Inc. grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 2.5% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 31,972 shares of the healthcare conglomerate’s stock after buying an additional 768 shares during the period. UnitedHealth Group accounts for about 1.3% of Neville Rodie & Shaw Inc.’s holdings, making the stock its 23rd largest holding. Neville Rodie & Shaw Inc.’s holdings in UnitedHealth Group were worth $15,367,000 as of its most recent SEC filing.
A number of other institutional investors also recently bought and sold shares of UNH. Moneta Group Investment Advisors LLC lifted its holdings in UnitedHealth Group by 100,076.4% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate’s stock worth $6,268,753,000 after buying an additional 11,812,017 shares during the last quarter. Norges Bank purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at about $5,210,004,000. Gateway Advisory LLC lifted its holdings in shares of UnitedHealth Group by 48,406.9% in the 1st quarter. Gateway Advisory LLC now owns 4,762,407 shares of the healthcare conglomerate’s stock valued at $4,762,000 after purchasing an additional 4,752,589 shares during the last quarter. Envestnet Asset Management Inc. lifted its holdings in shares of UnitedHealth Group by 264.2% in the 1st quarter. Envestnet Asset Management Inc. now owns 5,511,174 shares of the healthcare conglomerate’s stock valued at $732,934,000 after purchasing an additional 3,997,959 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership lifted its holdings in shares of UnitedHealth Group by 1,682.4% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,691,542 shares of the healthcare conglomerate’s stock valued at $1,372,606,000 after purchasing an additional 2,540,538 shares during the last quarter. 85.69% of the stock is owned by hedge funds and other institutional investors.
UnitedHealth Group Price Performance
Shares of NYSE:UNH opened at $486.70 on Friday. The business’s fifty day moving average price is $491.55 and its two-hundred day moving average price is $486.55. The stock has a market cap of $450.83 billion, a PE ratio of 21.78, a price-to-earnings-growth ratio of 1.42 and a beta of 0.66. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.80 and a current ratio of 0.80. UnitedHealth Group Incorporated has a one year low of $445.68 and a one year high of $558.10.
UnitedHealth Group Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 19th. Investors of record on Monday, September 11th will be issued a $1.88 dividend. This represents a $7.52 annualized dividend and a yield of 1.55%. The ex-dividend date of this dividend is Friday, September 8th. UnitedHealth Group’s dividend payout ratio is currently 33.65%.
Insider Activity at UnitedHealth Group
In other UnitedHealth Group news, CEO Andrew Witty sold 4,000 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, July 19th. The stock was sold at an average price of $506.19, for a total value of $2,024,760.00. Following the completion of the transaction, the chief executive officer now directly owns 78,573 shares in the company, valued at $39,772,866.87. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 0.35% of the stock is owned by corporate insiders.
Analysts Set New Price Targets
UNH has been the subject of several analyst reports. Sanford C. Bernstein raised UnitedHealth Group from a “market perform” rating to an “outperform” rating and upped their price objective for the company from $595.00 to $603.00 in a research note on Tuesday, July 18th. UBS Group upped their price objective on UnitedHealth Group from $510.00 to $520.00 and gave the company a “neutral” rating in a research note on Wednesday, July 19th. TD Cowen dropped their target price on UnitedHealth Group from $562.00 to $555.00 and set an “outperform” rating on the stock in a research report on Monday, July 17th. Piper Sandler assumed coverage on UnitedHealth Group in a research report on Thursday, May 25th. They set an “overweight” rating and a $580.00 target price on the stock. Finally, Stephens reiterated an “overweight” rating and set a $560.00 target price on shares of UnitedHealth Group in a research report on Friday, August 11th. Two research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $575.65.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
- Five stocks we like better than UnitedHealth Group
- How to Invest in Marijuana Stocks
- 5 Reasons Apple’s New Phone Moves the Needle: 5 That It Won’t
- CD Calculator: Certificate of Deposit Calculator
- MarketBeat Week in Review – 9/11 – 9/15
- How to Invest in the FAANG Stocks
- China’s Jump In Car Sales Is Drawing Big Money To These Stocks
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.